It is theoretically possible that new drugs like Ozempic and Wegovy, which are used to treat diabetes and obesity, respectively and can cause people to lose weight, could also be a factor
In a 71-week double-blind, placebo-controlled trial, 27.9% of participants with overweight or obesity taking oral semaglutide 25 mg lost 20% body weight at week 64, compared to 3.1% of the placebo group
What happens during the first two weeks The initial phase of a drug holiday is the hardest
Diabetologia 58 , 604614 (2015)
Abstract Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions
This doesn't mean eliminating them permanentlyjust reducing portions or spacing them further apart until your digestive system stabilizes